| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Clinical and Experimental Medicine, Padua University School of Medicine, Clinica Medica 1, Via Giustiniani 2, 35128 Padua [R. Z., L. T., M. F., A. C., R. S., A. M., C. T., C. A., G. S.], and Division of Hematology, Vicenza Hospital, 36100 Vicenza [R. Z. L. T., R. R.], Italy
To investigate whether cell populations in CD3+ lymphoproliferative disease of granular lymphocytes (LDGLs) were skewed toward the use of specific Vß regions, we studied the repertoire of T-cell receptor (TCR) Vß gene products in 18 patients, as well as their relationship to the clonal bands in the Southern blot and the activation mediated by superantigens.
Using a panel of monoclonal antibodies (mAbs) for conserved Vß segments and PCR, a dominant population expressing a specific Vß region was demonstrated in all patients. In five (27%) cases, granular lymphocytes (GLs) were found to express the Vß 13.1, while Vß8 and Vß6 were each expressed in three (17%) cases. The remaining cases were characterized by the proliferation of TCR Vß2, Vß3, Vß4, Vß9, Vß12, Vß16, and Vß20. This finding indicates a biased usage of a limited TCR Vß in LDGLs, since nearly 60% of the cases utilized only three families of the TCR Vß genes. In all of the cases studied, we proved that the subset recognized by mAb and PCR was identical to that accounting for the extra band(s) of the Southern blot. This finding confirms the clonal nature of the population identified according to TCR Vß expression both by phenotype and PCR. On functional grounds, we evaluated whether GLs can be activated through the specific TCR using the superantigens recognizing discrete Vß families, such as staphylococcal proteins, including SEA, SEB, SEC1, SEC2, SED, and SEE. We demonstrated that the TCR-
/ß of clonal GLs in LDGL patients is functionally active in delivering cytotoxic and proliferative signals upon superantigen activation.
1 This work was supported in part by Consiglio Nazionale delle Ricerche, Rome (Clinical Application of Oncological Research) and Associazione Italiana per la Ricerca sul Cancro, Milan.
2 To whom requests for reprints should be addressed, at Istituto di Medicina Clinica dell' Università di Padova, Clinica Medica 1, Via Giustiniani 2, 35128 Padua, Italy. Phone: 011-39-49-8212298; Fax: 011-39-49-8754179.
Received 7/20/95. Accepted 10/16/95.
This article has been cited by other articles:
![]() |
R. Zambello and G. Semenzato Large granular lymphocyte disorders: new etiopathogenetic clues as a rationale for innovative therapeutic approaches Haematologica, October 1, 2009; 94(10): 1341 - 1345. [Full Text] [PDF] |
||||
![]() |
L. Sokol and T. P. Loughran Jr. Large granular lymphocyte leukemia. Oncologist, March 1, 2006; 11(3): 263 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zambello, T. Berno, G. Cannas, I. Baesso, G. Binotto, E. Bonoldi, P. Bevilacqua, M. Miorin, M. Facco, L. Trentin, et al. Phenotypic and functional analyses of dendritic cells in patients with lymphoproliferative disease of granular lymphocytes (LDGL) Blood, December 1, 2005; 106(12): 3926 - 3931. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lima, J. Almeida, A. H. Santos, M. dos Anjos Teixeira, M. del Carmen Alguero, M. L. Queiros, A. Balanzategui, B. Justica, M. Gonzalez, J. F. San Miguel, et al. Immunophenotypic Analysis of the TCR-V{beta} Repertoire in 98 Persistent Expansions of CD3+/TCR-{alpha}{beta}+ Large Granular Lymphocytes : Utility in Assessing Clonality and Insights into the Pathogenesis of the Disease Am. J. Pathol., November 1, 2001; 159(5): 1861 - 1868. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Greer, M. C. Kinney, and T. P. Loughran Jr. T Cell and NK Cell Lymphoproliferative Disorders Hematology, January 1, 2001; 2001(1): 259 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zambello, L. Trentin, M. Facco, M. Siviero, S. Galvan, F. Piazza, A. Perin, C. Agostini, and G. Semenzato Analysis of TNF-receptor and ligand superfamily molecules in patients with lymphoproliferative disease of granular lymphocytes Blood, July 15, 2000; 96(2): 647 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Liu, S. Wei, T. Lamy, P. K. Epling-Burnette, G. Starkebaum, J. Y. Djeu, and T. P. Loughran Jr Chronic neutropenia mediated by Fas ligand Blood, May 15, 2000; 95(10): 3219 - 3222. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lamy, J. H. Liu, T. H. Landowski, W. S. Dalton, and T. P. Loughran Jr Dysregulation of CD95/CD95 Ligand-Apoptotic Pathway in CD3+ Large Granular Lymphocyte Leukemia Blood, December 15, 1998; 92(12): 4771 - 4777. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zambello, M. Facco, L. Trentin, R. Sancetta, C. Tassinari, A. Perin, A. Milani, G. Pizzolo, F. Rodeghiero, C. Agostini, et al. Interleukin-15 Triggers the Proliferation and Cytotoxicity of Granular Lymphocytes in Patients With Lymphoproliferative Disease of Granular Lymphocytes Blood, January 1, 1997; 89(1): 201 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Semenzato, R. Zambello, G. Starkebaum, K. Oshimi, and T. P. Loughran Jr The Lymphoproliferative Disease of Granular Lymphocytes: Updated Criteria for Diagnosis Blood, January 1, 1997; 89(1): 256 - 260. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |